Cargando…
Circulating tumor cells in peripheral blood as a diagnostic biomarker of breast cancer: A meta-analysis
PURPOSE: Studies have reported that breast cancer (BC) patients’ circulating tumor cells (CTCs) have varying results for their diagnostic role. Thus, we conducted a meta-analysis to systematically assess the accuracy of CTCs in the diagnosis of BC. METHODS: A meta-analysis was conducted to evaluate...
Autores principales: | Jin, Tao, Chen, Yao, Chen, Qing-Yan, Xiong, Yang, Yang, Ji-Qiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073650/ https://www.ncbi.nlm.nih.gov/pubmed/37035139 http://dx.doi.org/10.3389/fonc.2023.1103146 |
Ejemplares similares
-
Clinical diagnostic biomarker “circulating tumor cells” in breast cancer - a meta-analysis
por: Bai, Shiyan, et al.
Publicado: (2023) -
Targeted Next-Generation Sequencing of Circulating Tumor DNA, Bone Marrow, and Peripheral Blood Mononuclear Cells in Pediatric AML
por: Ruan, Min, et al.
Publicado: (2021) -
Circulating tumor cell associated white blood cell cluster as a biomarker for metastasis and recurrence in hepatocellular carcinoma
por: Chen, Jing, et al.
Publicado: (2022) -
Circulating Tumor-Cell-Associated White Blood Cell Clusters in Peripheral Blood Indicate Poor Prognosis in Patients With Hepatocellular Carcinoma
por: Luo, Qiong, et al.
Publicado: (2020) -
Are the Derived Indexes of Peripheral Whole Blood Cell Counts (NLR, PLR, LMR/MLR) Clinically Significant Prognostic Biomarkers in Multiple Myeloma? A Systematic Review And Meta-Analysis
por: Zhang, Xinwen, et al.
Publicado: (2021)